TSCORII: Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.

Sponsor
University of Aarhus (Other)
Overall Status
Unknown status
CT.gov ID
NCT01678274
Collaborator
(none)
106
1
34
3.1

Study Details

Study Description

Brief Summary

Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, hypertension, stroke and autoimmune diseases in general.

Our study aim is:
  • Using MRI to further characterize and find risk factors leading to aortic dilation.

  • Using MRI to assess the degree of aortic distensibility.

  • Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies.

  • Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.

Detailed Description

Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, congenital heart defects, hypertension, stroke, ovarian failure, infertility, decreased final height and autoimmune diseases in general

Our study aim is:
  • Using MRI to further characterize and find risk factors leading to aortic dilation.

  • Using MRI to describe aortic dimensions

  • Using MRI to assess the degree of aortic distensibility.

  • Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies.

  • Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.

Study Design

Study Type:
Observational
Actual Enrollment :
106 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Characterization of the Heart, Aorta and Blood Pressure in Women With Turner Syndrome. Association With Aortic Dissection.
Study Start Date :
Dec 1, 2013
Actual Primary Completion Date :
Mar 1, 2016
Anticipated Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Turner syndrome

Females with Turner syndrome

Control group

age matched females acting as controls

Outcome Measures

Primary Outcome Measures

  1. Aortic dimensions [Once]

    Aortic dimensions measured by MRI

  2. Agatston score [Once]

    Coronary CT evaluation of Agatston score

  3. Segment involvement score [Once]

    Segment involvement score (SIS) calculated as the sum of segments with one or more coronary plaques (score 0-18).

  4. Aortic distensibility [Once]

    Aortic distensibillity as measured by MRI

Secondary Outcome Measures

  1. 24 hour blood pressure [24 hour]

    24 hour blood pressure

  2. Pulse Wave Velocity [Once]

    Pulse Wave Velocity measured by applanation tonometry.

  3. Augmentation index [Once]

    Augmentation index measured by applanation tonometry.

  4. Central blood pressure [Once]

    Central blood pressure measured by applanation tonometry.

Other Outcome Measures

  1. echocardiography [Once]

    echocardiography evaluating Mitral and aortic valves, left ventricular hypertrophy, diastolic and systolic function etc..

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria with respect to individuals acting as controls:
  • Healthy age matched females
Exclusion Criteria:
  • Contraindications for MRI

  • Contraindications for CT

  • Severe obesity

  • Acute og Chronic disease with known or presumed significance with concern to outcomes of the study

  • Previous or present malignant disease

  • Clinically significant liver disease

  • Mechanic or biological heart valves

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Endocrinology and Internal medicine Aarhus Denmark 8000

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Study Chair: Claus H Gravholt, MD, Aarhus University Hospital
  • Principal Investigator: Christian Trolle, MD, Aarhus University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT01678274
Other Study ID Numbers:
  • 35202
First Posted:
Sep 3, 2012
Last Update Posted:
May 24, 2016
Last Verified:
Jun 1, 2015

Study Results

No Results Posted as of May 24, 2016